Literature DB >> 16446852

[Inflammatory bowel disease: experience of two Chilean centers].

Carolina Figueroa C1, Rodrigo Quera P, Jorge Valenzuela E, Christian Jensen B.   

Abstract

BACKGROUND: The incidence of Inflammatory Bowel Disease (IBD) has increased, particularly in the developed world, and probably also in Chile. AIM: To report our experience with a large group of patients from two medical centers, Hospital Clinico de la Universidad de Chile (HCUCH) and Clinica Las Condes (CLC) and to characterize the clinical features of IBD in Chile. PATIENTS AND METHODS: Retrospective review of 238 patients with IBD (age range 14-78 years, 143 women) treated at HCUCH and CLC between January 1990 and August 2002.
RESULTS: One hundred eighty one patients had ulcerative colitis (UC) and 57 had Crohn's disease (CD), with an UC/CD ratio of 3.2/1. Forty eight percent of patients were aged between 20 and 39 years old and 69% were diagnosed after 1995. Patients from HCUCH had more severe disease, more complications and needed surgery more often.
CONCLUSIONS: Clinical features of Chilean patients with IBD are similar to those of other countries. UC is more common than EC. There is a higher proportion of women with the disease. The severity of the disease was higher among HCUCH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16446852     DOI: /S0034-98872005001100004

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  10 in total

1.  Soluble ST2: a new and promising activity marker in ulcerative colitis.

Authors:  David Díaz-Jiménez; Lucía E Núñez; Caroll J Beltrán; Enzo Candia; Cristóbal Suazo; Manuel Alvarez-Lobos; María-Julieta González; Marcela A Hermoso; Rodrigo Quera
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012.

Authors:  Felipe Bellolio Roth; Javier Gómez; Jaime Cerda
Journal:  Dig Dis Sci       Date:  2017-06-30       Impact factor: 3.199

3.  Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.

Authors:  José Miguel Luz Parente; Claudio Saddy Rodrigues Coy; Viriato Campelo; Mírian Perpétua Palha Dias Parente; Leonardo Araújo Costa; Renata Mendes da Silva; Celso Stephan; José Murilo Robilotta Zeitune
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

4.  Pediatric Inflammatory Bowel Disease: A Multicenter Study of Changing Trends in Argentina Over the Past 30 Years.

Authors:  Maria Soledad Arcucci; Monica Beatriz Contreras; Julieta Gallo; Mariela Andrea Antoniska; Veronica Busoni; Cecilia Tennina; Daniel D'Agostino; Maria Hisae Kakisu; Christian Weyersberg; Marina Orsi
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-05-09

5.  Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome.

Authors:  Marjorie De la Fuente; Luigi Franchi; Daniela Araya; David Díaz-Jiménez; Mauricio Olivares; Manuel Álvarez-Lobos; Douglas Golenbock; María-Julieta González; Francisco López-Kostner; Rodrigo Quera; Gabriel Núñez; Roberto Vidal; Marcela A Hermoso
Journal:  Int J Med Microbiol       Date:  2014-02-06       Impact factor: 3.473

6.  Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.

Authors:  Daniela Simian; Daniela Fluxá; Lilian Flores; Jaime Lubascher; Patricio Ibáñez; Carolina Figueroa; Udo Kronberg; Raúl Acuña; Mauricio Moreno; Rodrigo Quera
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

7.  IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location.

Authors:  Rocio Sanchez; Emile Levy; Florin Costea; Daniel Sinnett
Journal:  World J Gastroenterol       Date:  2009-08-14       Impact factor: 5.742

8.  Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: the inflammatory bowel disease model.

Authors:  Andrew Szilagyi; Henry Leighton; Barry Burstein; Xiaoqing Xue
Journal:  Clin Epidemiol       Date:  2014-05-27       Impact factor: 4.790

9.  Inflammatory bowel disease epidemiology in São Paulo State, Brazil.

Authors:  Rodrigo Galhardi Gasparini; Ligia Yukie Sassaki; Rogerio Saad-Hossne
Journal:  Clin Exp Gastroenterol       Date:  2018-10-30

10.  Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study.

Authors:  Agustín Ciapponi; Sacha Alexis Virgilio; Mabel Berrueta; Natalie Claire Soto; Álvaro Ciganda; Moisés Freddy Rojas Illanes; Briseida Rubio Martinez; Johana Gamba; Carlos Arturo González Salazar; José Nicolás Rocha Rodríguez; Bruno Scarpellini; Ana María Bravo Perdomo; Gerardo Machnicki; Leandro Aldunate; Juan De Paula; Ariel Bardach
Journal:  PLoS One       Date:  2020-01-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.